The largest database of trusted experimental protocols

AD 20

AD 20: A cutting-edge AI-powered platform that revolutionizes research accuracy by optimizing protocols for Alzheimer's disease (AD).
Discover and compare protocols from a vast repository of literature, preprints, and patents to identify the most effective solutions for your AD research needs.
Leverage the power of AI-driven comparisons to maximize efficiency and productivity, taking your research to new heights.
Experience the future of research today with PubCompare.ai and unlock unprecedented insights into AD treatments and therapies.

Most cited protocols related to «AD 20»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2010
AD 20 Animals Body Weight Diet, High-Fat Fishes Food Males Menhaden oil Mice, House Oils, Fish Specific Pathogen Free Therapy, Diet
Our study populations consisted of 40 participants (20 with mild cognitive impairment [MCI], 20 with AD) who underwent structural MRI and PET imaging sessions with PiB and flutemetamol within a <40 day time period at several centers in Europe as described previously [2 (link)]. The other sample consisted of 32 cognitively normal, MCI, and AD participants from the Alzheimer’s Disease Neuroimaging Initiative (see below) who underwent structural MRI and PET imaging sessions with PiB and florbetapir with an approximately 1.5 years apart as described previously [6 (link)]. All participants gave written informed consent that was approved by the Internal Review Board of each participating institution.
Publication 2014
AD 20 Alzheimer's Disease Cognitive Impairments, Mild Ethics Committees, Research florbetapir flutemetamol Population Group
To synthesize cDNA, we transcribed a standardized quantity of 1 µg RNA per sample using a random hexamer primer (0.1 nmol, 1 µl, SO142, Life Technologies GmbH, Darmstadt, Germany), an oligo-dT18 primer (0.1 nmol, 1 µl, SO131, Life Technologies), 5 × M-MLV-buffer (4 µl, M1705, Promega, Fitchburg, WI, USA) and dNTP mix (40 nmol, 1 µl–10 nmol/dNTP, Roti®-Mix PCR3, L785.2, Carl-Roth GmbH) ad 20 µl nuclease-free H2O (T143, Carl-Roth GmbH). After incubation (3 min, 70 °C) the mixture was quickly cooled on ice. We then added reverse transcriptase (200 U, 1 µl, M1705, Promega) and an RNase inhibitor (40 U, 1 µl, EO0381, Life Technologies), continued incubation (37 °C, 60 min) and heat-inactivated the reverse transcriptase (95 °C, 2 min). To minimize experimental variations, synthesis of cDNA, which was stored at −20 °C until use, was performed concurrently for all samples.
Full text: Click here
Publication 2017
AD 20 Anabolism Buffers DNA, Complementary Endoribonucleases Oligonucleotide Primers Oligonucleotides Promega RNA-Directed DNA Polymerase

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2016
AD 20 Adult Animals, Laboratory Cereals Feeding Behaviors Light Males Medical Devices Mice, House Mice, Inbred C57BL Pellets, Drug Satiation
Except for the CSF replication 3 samples, all CSF samples used in this study were collected under the auspices of the Emory ADRC or closely affiliated research institutions. In total, there were four cohorts of Emory CSF samples used in these proteomics studies. The discovery CSF cohort contained samples from 20 healthy controls and 20 patients with AD. CSF replication 1 included samples from 32 healthy controls, 31 individuals with AsymAD, and 33 individuals with AD. CSF replication 2 contained 147 control and 150 AD samples. The multidisease CSF replication 4 cohort comprised 18 control, 17 AD, 19 ALS, 13 PD, and 11 FTD samples. All Emory research participants were provided informed consent under protocols approved by the Institutional Review Board at Emory University. CSF was collected by lumbar puncture and banked according to the 2014 National Institute on Aging best practice guidelines for Alzheimer’s Disease Centers (https://alz.washington.edu/BiospecimenTaskForce.html). Control and patients with AsymAD and AD received standardized cognitive assessments in the Emory Cognitive Neurology Clinic or Goizueta ADRC and their CSF samples subjected to ELISA Aβ1–42, total tau, and p-tau analysis by the INNO-BIA AlzBio3 Luminex Assay (65 (link)). The ELISA values were used to support subject diagnostic classifications based on established AD biomarker cutoff criteria (66 (link), 67 (link)). Basic demographic and diagnostic data for other CSF diagnoses (FTD, ALS, and PD) were also obtained from the Emory ADRC or affiliated research institutions. Summarized case metadata for these Emory CSF cases can be found in table S1A. Characteristics of the Swiss CSF replication 3 cohort were previously published (45 (link)).
Publication 2020
AD 20 Biological Assay Biological Markers Cognition Diagnosis DNA Replication Enzyme-Linked Immunosorbent Assay Ethics Committees, Research Macrophage Colony-Stimulating Factor Neurologic Examination Patients Punctures, Lumbar sargramostim

Most recents protocols related to «AD 20»

Colonies of bumblebees (Bombus terrestris audax) were obtained from Agralan, (Swindon, United Kingdom) or Koppert Biological Systems Nederland (Berkel en Rodenrijs, the Netherlands). Bees were housed in 30.0 × 14.0 × 16.0 cm bipartite wooden nest boxes, and all individuals were marked with numbered Opalith tags for individual identification during transfer to these nest boxes. This involved trapping each bee in a small cage, gently pressing it against the mesh with a sponge, and affixing the tag to the dorsal thorax with a small amount of glue. The nest boxes were connected to flight arenas (66.0 × 60.0 × 30.0 cm or 132.0 × 60.0 × 30.0 cm for single- and multiple-demonstrator experiments, respectively) via 26.0 × 3.5 × 3.5 cm clear acrylic tunnels, which could be blocked to limit access to the flight arena. Bees were allowed to forage ad libitum on 20% w/w sucrose solution provided in mass feeders in these arenas overnight, and pollen was provided every 2 days. Colonies were maintained at standardised room temperature throughout the study, and experiments were conducted under standardised artificial lights (12:12, high-frequency fluorescent lighting; TMS 24F lamps with HF-B 236 TLD [4.3 kHz] ballasts [Koninklijke Phillips NV, Amsterdam, the Netherlands], fitted with Activa daylight fluorescent tubes [OSRAM Licht AG, Munich, Germany]).
Full text: Click here
Publication 2023
AD 20 Audax Bees Biopharmaceuticals Chest Pollen Porifera Sucrose
The concentration of adenine nucleotides (ATP, ADP, AMP) and adenosine (Ado) released into the culture medium were determined using HPLC. The medium (400 µl) was transferred into a cold Eppendorf tube containing 50 µl of 0.1 m perchloric acid and 10 μm theophylline (as an internal standard). The medium was centrifuged (at 3510 × g for 10 min at 0°C-4°C), and the supernatant was kept at −20°C until analysis. Online solid phase extraction coupled to the column-switching technique was applied for quantification of nucleotide content in the samples. HPLC separation was performed by a Shimadzu LC-20 AD Analytical System using UV (Agilent 1100 VW, set at 253 nm) detection. A phenyl-hexyl packed (7.5 × 2.1 mm) column was used for online sample enrichment, and separation was completed by coupling to an analytical C-18 (150 × 2.1 mm) column. The flow rates of the mobile phases [Phase A: 10 mm potassium phosphate buffer with 0.25 mm EDTA; Phase B: additional components, such as 0.45 mm octane sulfonyl acid sodium salt, 8% acetonitrile (v/v), 2% methanol (v/v), pH 5.55] were 350 and 450 µl/min, and they were applied in a step gradient (Baranyi et al., 2006 (link)). The sample enrichment flow rate of buffer A was 300 µl/min for 4 min, and the total run time was 55 min. Concentrations were calculated by an internal standard 2 point calibration curve method [(Ai × f × B)/(C × Di), where Ai is the area of nucleotide components, B is the sample volume, C is the injection volume, Di is the response factor for 1 pmol nucleotide standard, and f is the international standard factor (IS area in the calibration/IS area in the actual sample)]. The data are expressed as pmol per ml.
Full text: Click here
Publication 2023
acetonitrile Acids AD 20 Adenine Nucleotides Adenosine AT 3510 Buffers Cold Temperature Edetic Acid Edetic Acid, Potassium Salt High-Performance Liquid Chromatographies Methanol Nucleotides octane Perchloric Acid Phosphates potassium phosphate Sodium Sodium Chloride Solid Phase Extraction Theophylline
Chemicals such as sodium hydroxide (NaOH), 3-aminopropyl-trimethoxysilane (APTMS), and dimethyl sulfoxide (DMSO) were obtained from the Chengdu Kelong chemical reagent factory (Chengdu, China). Monoamine oxidase B (MAO-B, 100.23 U/mL) was prepared in-house [12 (link)]. Kynuramine dihydrobromide was purchased from Sigma-Aldrich (St Louis, MO, USA). Safinamide mesylate and rasagiline were purchased from Meilunbio (Dalian, China). The MAO-B inhibition assay was carried out using Thermo Scientific Varioskan Flash equipped with a 96-well microplate (Thermo, Waltham, MA, USA). FT-IR spectra were recorded in KBr with a PerkinElmer FT-IR spectroscope (PerkinElmer, Waltham, MA, USA). Ultrapure water produced with a UP water purification (18.25 MΩ) system (Ultrapure, Chengdu, China) was used for HPLC. HPLC-grade methanol was obtained from JT Baker (Phillipsburg, NJ, USA). The HPLC system consisted of a Shimadzu LC-20 AD series equipped with a thermostatic column compartment, an SPD20A UV-vis detector (Shimadzu, Kyoto, Japan), and an Agilent ZORBAX SB-C18 column (4.6 × 250 mm, 5 μm). The mobile phase was composed of solvent A (0.1%, v/v, formic acid/H2O) and solvent B (100% MeOH) at a flow rate of 0.8 mL/min, and an injection volume of 20 µL. The eluting gradient was set to 30–100% MeOH for 0–30 min. The MS detection was in the positive ion mode using a capillary voltage of 3.0 kV; a source temperature of 180 °C; a desolvation temperature of 350 °C; and a desolvation gas flow of 800 L/h, while the nebulizer was set at 0.8 Bar and the sample flow rate was set at 0.3 mL/min for the ESI-MS (Bruker Compass Data Analysis 4.0; microTOF-Q11-10203). For the FT-IR, the samples were pretreated with a tablet press using potassium bromide (KBr) in a dry environment, and the wavenumbers of the FT-IR measurement were set in the range of 450 to 4500 cm−1.
Full text: Click here
Publication 2023
AD 20 Biological Assay Capillaries formic acid High-Performance Liquid Chromatographies Infrared Spectrophotometry Kynuramine Methanol Monoamine Oxidase B Nebulizers Psychological Inhibition rasagiline safinamide methanesulfonate Sodium Hydroxide Solvents Spectrum Analysis Sulfoxide, Dimethyl Tablet trimethoxysilane
UaB was chemically profiled to identify its
putative secondary metabolites using untargeted LC-HRMS analysis.
This was performed on a Shimadzu LC-20 AD apparatus equipped with
an autosampler (SIL-20A, Shimadzu), a diode array detector (SPD-M20AV,
Shimadzu), and coupled with a microToF II (Bruker Daltonics) ESI-QToF
mass spectrometer. High-performance liquid chromatography column Chromolith
Performance RP-18e (2.0 × 100 mm2 i.d.) was used for
the analysis. The eluents were acetonitrile and water with 0.1% acetic
acid. After injecting 5 μL of the UaB fraction, flow elution
was set at 0.2 mL/min. The peaks were monitored at 350 nm. The mass
spectra were recorded in the mass range m/z 50–2000. Bruker DataAnalysis 4.3 software (Bruker,
Germany) was used for data acquisition and analysis. Individual components
were identified by comparison of their m/z values in the total ion count profile with those compounds
described in the literature or by matching their MS/MS spectra with
those reported in a public repository of mass spectral data called
MassBank.
Publication 2023
acetonitrile AD 20 High-Performance Liquid Chromatographies Tandem Mass Spectrometry
This study included three separate research cohorts. The first cohort was the Translational Biomarkers in Aging and Dementia (TRIAD) study17 recruiting from the McGill Centre for Studies in Aging in Montreal, Canada. The second and third cohorts were the Swedish BioFINDER‐118 and BioFINDER‐219 studies, both recruiting from Skåne University Hospital and the Hospital of Ängelholm, Sweden. In all three cohorts, inclusion was based on (i) being cognitively unimpaired (CU)—that is, did not have MCI or dementia—and above age 60, (ii) fulfilling clinical criteria for probable AD20 or a non‐AD dementia disorder, and (iii) availability of all three ATN biomarkers. Table S1 presents a breakdown of the non‐AD neurodegenerative diseases in each cohort. Participants were excluded if they had inadequately treated systemic conditions, active substance abuse, recent head trauma, major surgery, or presented with magnetic resonance imaging (MRI)/PET safety contraindications. Full details of inclusion and exclusion criteria for all studies have been published previously17, 18, 19 and are provided in Supplementary Methods 1.
Written informed consent was obtained for all participants. The TRIAD study was approved by the Montreal Neurological Instituted PET Working Committee and the Douglas Mental Health University Institute Research Ethics Board. Ethical approval for the BioFINDER‐1 and BioFINDER‐2 studies was given by the Regional Ethical Committee in Lund, Sweden. Approval for PET imaging was obtained from the Swedish Medicines and Products Agency and the local radiation safety committee at Skåne University Hospital, Lund, Sweden.
Publication 2023
AD 20 Biological Markers Catabolism Craniocerebral Trauma Dementia Mental Health Neurodegenerative Disorders Operative Surgical Procedures Pharmaceutical Preparations Presenile Dementia Protein Biosynthesis Radiotherapy Safety Substance Abuse Triad resin

Top products related to «AD 20»

Sourced in Japan, United States, Italy, Germany
The LC-20AD is a versatile high-performance liquid chromatography (HPLC) pump from Shimadzu. It is designed to provide precise and reliable solvent delivery for analytical and preparative HPLC applications. The pump features a dual-piston design for consistent flow rates, and can operate at pressures up to 40 MPa.
Sourced in Japan, United States, Germany, Australia, Switzerland, China, United Kingdom, France, Italy, India
The HPLC system from Shimadzu is a high-performance liquid chromatography instrument used for the separation, identification, and quantification of various chemical compounds in a sample. It consists of a solvent delivery system, a sample injection mechanism, a separation column, a detection system, and a data processing unit. The core function of the HPLC system is to provide efficient and accurate analysis of complex mixtures by separating the individual components based on their physical and chemical properties.
Sourced in Japan, United States, Germany, Italy, Canada, China, Spain
The Shimadzu LC-20AD is a high-performance liquid chromatography (HPLC) pump. It is designed to deliver accurate and consistent solvent flow for separating and analyzing a wide range of samples in liquid chromatography applications.
Sourced in United States
Male FVB mice are a mouse strain commonly used in biomedical research. They are inbred laboratory mice that carry the FVB genetic background.
Sourced in United States, Canada, Japan, Germany, Austria, China, Switzerland
The QTRAP 5500 mass spectrometer is a high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) system. It is designed to provide sensitive and selective analysis of small molecules. The instrument features a triple quadrupole configuration and advanced ion optics for efficient ion transmission and fragmentation.
Sourced in Japan, United States, United Kingdom
The Prominence UFLC system is an ultra-fast liquid chromatography (UFLC) instrument manufactured by Shimadzu. The core function of this system is to perform high-performance liquid chromatography (HPLC) analysis with increased speed and efficiency.
Sourced in United States, China, Germany, United Kingdom, Canada, Japan, France, Italy, Switzerland, Australia, Spain, Belgium, Denmark, Singapore, India, Netherlands, Sweden, New Zealand, Portugal, Poland, Israel, Lithuania, Hong Kong, Argentina, Ireland, Austria, Czechia, Cameroon, Taiwan, Province of China, Morocco
Lipofectamine 2000 is a cationic lipid-based transfection reagent designed for efficient and reliable delivery of nucleic acids, such as plasmid DNA and small interfering RNA (siRNA), into a wide range of eukaryotic cell types. It facilitates the formation of complexes between the nucleic acid and the lipid components, which can then be introduced into cells to enable gene expression or gene silencing studies.
Sourced in United States, Canada, Japan, Singapore, China
The Triple TOF 5600 System is a high-resolution, high-mass-accuracy mass spectrometry platform designed for a wide range of analytical applications. It combines a triple quadrupole configuration with a time-of-flight (TOF) mass analyzer, providing precise quantitation and accurate qualitative analysis.
Sourced in Japan, United States, Germany
The SIL-20AC autosampler is a laboratory equipment piece designed to automatically inject samples into an analytical instrument, such as a liquid chromatograph. It is capable of handling a wide range of sample volumes and vial sizes, allowing for efficient and consistent sample processing.
Sourced in Japan
The SPD-M20AV is a photodiode array (PDA) detector for high-performance liquid chromatography (HPLC) systems. It is designed to provide sensitive and reliable detection of a wide range of compounds. The SPD-M20AV collects and processes spectral data across a broad wavelength range, enabling comprehensive analysis of sample components.

More about "AD 20"

Alzheimer's disease (AD) is a devastating neurodegenerative condition that affects millions of individuals worldwide.
AD 20 is a cutting-edge AI-powered platform that revolutionizes research accuracy by optimizing protocols for this debilitating disease.
Leveraging the power of artificial intelligence, AD 20 allows researchers to discover and compare a vast repository of protocols from literature, preprints, and patents, enabling them to identify the most effective solutions for their AD research needs.
The LC-20AD pump and Prominence UFLC system are crucial components of the analytical workflow, enabling high-performance liquid chromatography (HPLC) analysis for AD research.
The QTRAP 5500 mass spectrometer and Triple TOF 5600 System provide advanced mass spectrometry capabilities, allowing for the precise identification and quantification of AD-related biomarkers and therapeutic compounds.
The SIL-20AC autosampler ensures efficient and automated sample handling, while the Lipofectamine 2000 reagent facilitates the transfection of cells for in vitro studies.
Male FVB mice are commonly used as animal models in AD research, providing valuable insights into the underlying mechanisms and potential treatments.
By leveraging the AI-driven comparisons and optimization capabilities of AD 20, researchers can maximize their efficiency and productivity, taking their AD research to new heights.
Discover the future of research today with PubCompare.ai and unlock unprecedented insights into AD treatments and therapies.